Epstein-Barr virus-associated primary central nervous system cytotoxic T-cell lymphoma

Neuropathology

Volumn 33, Issue 4, 2013, Pages 436-441

  Ogura, Ryosuke ^a   Aoki, Hiroshi ^a   Natsumeda, Manabu ^a   Shimizu, Hiroshi ^a   Kobayashi, Tsutomu ^a   Saito, Tomohisa ^b   Takizawa, Jun ^c   Okamoto, Kouichirou ^a   Hasegawa, Go ^c   Umezu, Hajime ^d   Ohshima, Kouichi ^e   Takahashi, Hitoshi ^a   Fujii, Yukihiko ^a   Kakita, Akiyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Kaetsu Hospital   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^e KURUME UNIVERSITY   (Japan)

Author keywords

CD8; Cytotoxic T cell; Epstein Barr virus; NK T cell lymphoma; Pathology; Primary central nervous system lymphoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; GRANZYME B; PERFORIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

AGED; ARTICLE; AUTOPSY; BRAIN BIOPSY; CASE REPORT; CD8+ T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; TEMPORAL LOBE;

CD8; CYTOTOXIC T-CELL; EPSTEIN-BARR VIRUS; NK/T-CELL LYMPHOMA; PATHOLOGY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;

AGED; BRAIN NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 84881315954     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12005     Document Type: Article

References (23)

1. Oyama T, Ichimura K, Suzuki R etal. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003; 27: 16-26.
2. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768.
3. Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. The characteristic of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV (+) and EBV (-) cases in Japanese population. Jpn J Cancer Res 2000; 91: 1233-1240.
4. Park S, Lee J, Ko YH etal. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007; 110: 972-978.
5. Kwong Y-L. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005; 19: 2186-2194.
6. Cobo F, Talaver P, Busquier H, Concha Á. CNK/T-cell brain lymphoma associated with Epstein-Barr virus in a patient with AIDS. Neuropathology 2007; 27: 396-402.
7. Guan H, Huang Y, Wen W, Xu M, Zan Q, Zhang Z. Primary central nervous system extranodal NK/T-cell lymphoma, nasal type: case report and review of the literature. J Neurooncol 2011; 103: 387-391.
8. Kaluza V, Rao DS, Said JW, de Vos S. Primary extranodal nasal-type natural killer/T cell lymphoma of the brain: a case report. Hum Pathol 2006; 37: 769-772.
9. Liu JK, Sayama C, Chin SS, Couldwell WT. Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg 2007; 107: 660-665.
10. Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC. Extranodal NK/T cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL etal., eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: IARC, 2008; 285-288.
11. Ng SB, Lai KW, Murugaya S etal. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic study of 42 cases in Singapore. Mod Pathol 2004; 17: 1097-1107.
12. Ohshima K, Kimura H, Yoshino T etal. Proposed categorization of pathological states of EBV-associated T-natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008; 58: 209-217.
13. Aoyama T. Pathological classification and detection of monoclonality in malignant lymphoma. Niigata Med J 2009; 123: 404-412. (in Japanese.)
14. Luther N, Greenfield JP, Chadburn A, Schwartz TH. Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature. J Neurooncol 2005; 75: 185-188.
15. Schwaighofer BW, Hesselink JR, Press GA, Wolf RL, Hearly ME, Berthoty DP. Primary intracranial CNS lymphoma: MR manifestations. AJNR Am J Neuroradiol 1989; 10: 725-729.
16. Johnson BA, Fram EK, Johnson PC, Jacobowitz R. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol 1997; 18: 563-572.
17. Okano M, Kawa K, Kimura H etal. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005; 80: 64-69.
18. Nishihara H, Tateishi U, Itoh T, Nagashima K, Tanaka S. Immunohistochemical and gene rearrangement studies of central nervous system lymphomatoid granulomatosis. Neuropathology 2007; 27: 413-418.
19. Cooke CB, Krenacs L, Stetler-Stevenson M etal. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 1996; 88: 4265-4274.
20. Kitai R, Matsuda K, Adachi E etal. Epstein-Barr virus associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 2010; 50: 114-118.
21. Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K. Epstein-Barr (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time? Brain Tumor Pathol 2011; 28: 145-149.
22. Jahnke K, Muldoon LL, Varallyay CG etal. Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma. Neuro Oncol 2009; 11: 503-513.
23. Roychowdhury S, Peng R, Baiocchi RA etal. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res 2003; 63: 965-971.